Globe Life files Form 144 to sell 10,500 shares

Globe Life Inc. notice of proposed sale of 10,500 common shares under Form 144.

Rhea-AI Filing Summary

Globe Life Inc. notice of proposed sale of 10,500 common shares under Form 144. The filing lists a market value/aggregate of 1533840.00 and shows 78,502,724 shares outstanding as of 02/27/2026 as a context figure. The excerpt also records a prior sale of 10,000 common shares on 02/12/2026 for 1431355.35 by Jennifer Haworth.

Insights

Securities Compliance Analyst

Routine Form 144 sale notice; records proposed sale and a recent prior sale.

The filing lists a proposed sale of 10,500 common shares with an aggregate figure of 1533840.00, and separately documents a sale of 10,000 common shares on 02/12/2026 for 1431355.35 by Jennifer Haworth. These items fit Form 144’s role as a notice of proposed broker-assisted resale.

Timing and final execution depend on compliance with Rule 144 requirements and broker settlement; the excerpt does not state clearance, proceeds recipient, or additional transfer conditions. Subsequent filings or broker confirmations would show completion and any cash‑flow treatment.

FAQ

What does Globe Life (GL) report in this Form 144?

The Form 144 reports a proposed sale of 10,500 common shares with an aggregate figure of 1533840.00. It also records a prior sale of 10,000 common shares on 02/12/2026 for 1431355.35 by Jennifer Haworth.

Who is the selling party named in the Globe Life Form 144 excerpt?

The excerpt identifies Jennifer Haworth as a seller who completed a sale of 10,000 common shares on 02/12/2026 for 1431355.35. The proposed sale of 10,500 shares is listed separately in the filing.

How many Globe Life shares are shown outstanding in this filing?

The filing shows 78,502,724 shares outstanding as of 02/27/2026. This figure is presented as a context number in the excerpt and is not described as part of the amount being sold in the Form 144 notice.

Does this Form 144 confirm the sales have settled for Globe Life shares?

No. The Form 144 lists a proposed sale of 10,500 shares and records a past sale of 10,000 shares on 02/12/2026, but it does not provide settlement confirmations or state who received proceeds for the proposed sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/02/2026 - 09:35 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001799762
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Globe Life Inc
SEC File Number	001-08052
Address of Issuer	7677 Henneman Way, McKinney TEXAS 75070
Phone	972.569.4000
Name of Person for Whose Account the Securities are To Be Sold	Jennifer Haworth
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	OFFICER

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	APEX CLEARING 350 N ST. PAUL ST, SUITE 300 DALLAS TX 75201	10500	1533840.00	78502724	02/27/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	02/28/2019	Stock Option Exercise	Globe life Inc			10500	02/27/2026	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jennifer Haworth 7677 Henneman Way McKinney TX 75070	COMMON	02/12/2026	10000	1431355.35

144: Remarks and Signature

Remarks
Date of Notice	02/27/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jennifer A. Haworth
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)